CE vs PRCT · rev $10.28B vs rev $224.5M
Celanese Corporation (CE) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
CE currently screens at market cap $5.92B. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the CE and PRCT stock pages for the full models.
Not investment advice.